Skip to content

PHOTOS: Amid Federal Funding Cuts & Uncertainty, Senator Peters Visits MSU Biomedical Research Institute to Highlight Importance of Federal Support for Solving Today’s Pressing Healthcare Challenges

During Tour, MSU Faculty & Students Demonstrated Cutting-Edge Research Made Possible by National Institutes of Health, National Science Foundation Grant Funding

EAST LANSING, MI – U.S. Senator Gary Peters (MI) visited Michigan State University (MSU) to tour the Institute for Quantitative Health Science and Engineering (IQ) and highlight the importance of federal funding for solving the most pressing challenges in healthcare. During the tour, MSU faculty and students demonstrated the innovative research and technologies made possible by grants from the National Institutes of Health (NIH) and National Science Foundation (NSF), including cancer-sniffing insects, cardiac organoid models and wearable monitoring systems.  

Peters was joined by Dr. Christopher Contag, Director of the Institute for Quantitative Health Science and Engineering, and Dr. Jinxing Li, Assistant Professor of the Department of Biomedical Engineering. During a press conference following the tour, Peters underscored the challenges that research institutions like MSU currently face amid federal funding cuts and uncertainty, which are impacting IQ’s ability to continue developing cutting-edge research that keeps Michiganders safe and healthy.  

“As we saw firsthand today, the students and faculty at Michigan State University are developing cutting-edge health care solutions that will transform the way we can care for our patients and keep Michiganders healthy. However, recent executive orders made by the current administration have either stalled or completely terminated the federal funding that research institutions like MSU rely on to carry out this important work,” said Senator Peters. “These cuts are a big mistake. That’s why I made it a priority to come to MSU today to highlight how federal investments in research and innovation are effective and invaluable to our society.” 

“At IQ, our biomedical research drives bold innovation — from “first-ever discovery” to “first-in-human” application. We’re not just focused on uncovering new biology, technologies, and therapeutic approaches; we’re committed to translating these breakthroughs into real-world impact,” said Dr. Christopher Contag. “I’d like to thank Senator Peters for coming here today to learn more about our mission, which is to lead at the frontier of discovery and be the first to bring those innovations to patients. With vital support from federal funding, we turn transformative ideas into solutions that can improve and save lives.”  

“Earlier this year, I was thrilled to learn from a representative of Senator Peters’ office that my research project was set to receive funding from the National Institutes of Health,” said Dr. Jinxing Li. “However, the project has been delayed and is awaiting final funding authorization. Without a reliable funding timeline, we were unable to begin planning or recruiting the talented scientists needed to carry out this critical work. This experience underscores how timely and consistent federal support is essential to sustaining innovation, and we are grateful to Senator Peters for his continued advocacy for science, innovation, and the future of healthcare.”

To download photos from Peters’ event at MSU, click here.

MSU's Institute for Quantitative Health Science and Engineering (IQ) integrates a variety of researchers across scientistic disciplines to solves some of today’s most pressing issues in healthcare including cancer research, studying heart defects, and delivering therapies to treat muscular disfunction, all of which are supported by NIH and NSF grant funding. Peters, a graduate of MSU, has remained committed to the continued renewal of these grants and ensuring researchers at MSU and across Michigan have access to this funding. As a member of the Appropriations Committee, Peters secured over $50 billion in the government funding bill that was signed into law last year for the NIH to support biomedical research and support institutions like the IQ Lab.  

###